Today we announce the closing of Section 32 Fund 4, raising approximately $740M million from returning and new investors. Some statistics to mark the occasion: Section 32 has more than $1.8 billion of assets under management and more than 70 companies in the portfolio. Our goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life saving medicines.
Section 32 invests across the entirety of technology and healthcare. This includes software, cybersecurity, advanced communications and computation, space, climate change related technologies, machine learning, artificial intelligence, biotechnology, therapeutics, advanced diagnostics, precision medicine, genomics and more.
To further support the firm’s growth, we are pleased to announce the addition of Nina Labatt as COO and CFO. Most recently serving as chief operating officer and general partner at Trinity Ventures, Nina has two decades of experience and is recognized as an industry expert for creating finance and back-office operations in VC.
We’ve also launched a fresh look which you can see at section32.com.